Filing Details

Accession Number:
0000899243-21-036419
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-17 16:38:38
Reporting Period:
2021-09-17
Accepted Time:
2021-09-17 16:38:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1863127 Tyra Biosciences Inc. TYRA () 1231
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1015747 Joseph Lewis C/o Cay House P.o. Box N-7776 E.p.
Taylor Drive Lyford Cay
New Providence C5
No No Yes No
1465836 Boxer Asset Management Inc. C/o Cay House P.o. Box N-7776 E.p.
Taylor Drive Lyford Cay
New Providence C5 N7776
No No Yes No
1465837 Boxer Capital, Llc 12860 El Camino Real, Suite 300
San Diego CA 92130
No No Yes No
1465914 I. Aaron Davis 12860 El Camino Real, Suite 300
San Diego CA 92130
No No Yes No
1468223 Mva Investors, Llc 12860 El Camino Real, Suite 300
San Diego CA 92130
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-17 5,698,359 $0.00 5,698,359 No 4 C Direct
Common Stock Acquisiton 2021-09-17 625,000 $16.00 6,323,359 No 4 P Direct
Common Stock Acquisiton 2021-09-17 288,095 $0.00 288,095 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2021-09-17 1,480,242 $0.00 3,844,780 $0.00
Common Stock Series A Preferred Stock Disposition 2021-09-17 95,516 $0.00 248,093 $0.00
Common Stock Series B Preferred Stock Disposition 2021-09-17 713,629 $0.00 1,853,579 $0.00
Common Stock Series B Preferred Stock Disposition 2021-09-17 15,401 $0.00 40,002 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  2. These securities are held directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Joseph C. Lewis, (iv) MVA Investors, LLC and (v) Aaron I. Davis (collectively, the "Boxer Group"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
  3. These securities are held directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.